Download:
pdf |
pdfAttachment A
U.S. DEPARTMENT OF COMMERCE
Economics and Statistics Administration
U.S. CENSUS BUREAU
FORM
BRD-1
11017019
2017 BUSINESS RESEARCH
AND DEVELOPMENT SURVEY
(10-27-2017) Draft 8
DUE DATE:
Need help or have
questions about filling
out the form?
Visit https://www.census.gov/
programs-surveys/brds/
information.html
Here, you can access
question-by-question detailed
instructions and learn more
about the survey.
Call toll-free 1-800-772-7851,
between 8:00 a.m. and
5:00 p.m. Eastern time,
Monday through Friday.
Please file your form
electronically (see details
below).
Or mail your completed
form to:
U.S. CENSUS BUREAU
4600 Silver Hill Road
Room ERD-6H156
Washington, DC 20233
(Please correct any errors in this mailing address)
INTERNET REPORTING OPTION AVAILABLE
Please complete this survey online at: https://portal.census.gov
Authentication Code:
YOUR RESPONSE IS REQUIRED BY LAW. Title 13, United States Code, Sections 8(b), 131, and 182,
and Title 42, United States Code, Sections 1861-76 (National Science Foundation Act of 1950, as
amended) authorize this collection. Title 13, United States Code, Sections 224 and 225 require your
response. The U.S. Census Bureau is required by Section 9 of the same law to keep your information
CONFIDENTIAL and can use your responses only to produce statistics. The Census Bureau is not
permitted to publicly release your responses in a way that could identify your business, organization,
or institution. Per the Federal Cybersecurity Enhancement Act of 2015, your data are protected from
cybersecurity risks through screening of the systems that transmit your data.
THIS COLLECTION HAS BEEN APPROVED by the Office of Management and Budget (OMB). The
eight-digit OMB approval number is 0607-0912 and appears at the upper right corner of this page.
Without this approval, we could not conduct this survey.
We estimate this survey will take an average of 3.3 hours to complete. More information about this
estimate and an address where you may write with comments is on the back of this form.
THANK YOU – YOUR RESPONSE IS IMPORTANT. Accurate and timely statistical information could
not be produced without your cooperation and goodwill. Thank you.
∼ This survey is jointly conducted by the U.S. Census Bureau and the National Science Foundation ∼
§,"g4¤
11017027
Table of Contents
This survey is divided into seven sections based on subject matter. You may need to collaborate with
colleagues in different departments to complete all sections. The following table of contents summarizes
the subject matter covered by each section and what is required to complete them.
Section 1: Company Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.4
Topics include company ownership, business activities, revenues, and employees.
Section 2: R&D Paid For by Your Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.8
Topics include geographic location and accounting details related to R&D expenses.
Section 3: Costs Paid For by Others . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.19
Topics include customer-sponsored work and activities funded through grants and/or reimbursements.
Section 4: Capital Expenditures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.34
Topics include company expenditures for property, plant, and equipment including capitalized software.
Section 5: Management and Strategy of R&D . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.35
Topics include characteristics of R&D reported in Sections 2 and 3. Requires familiarity with the
technical and strategic aspects of your company’s R&D.
Section 6: Human Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.40
Topics include your company’s employees, focusing on those who work on R&D activities.
Section 7: Intellectual Property and Technology Transfer . . . . . . . . . . . . . . . . . . p.43
Topics include patenting, licensing, and other technology transfer activities.
Changes from the 2016 survey
Questions related to product and process innovation have been removed. Questions related to capital
expenditures have been moved to their own section. Skip patterns have been introduced to reduce the
number of questions companies with relatively small R&D expenditures are required to answer. For a
list of specific changes, go to https://www.census.gov/programs-surveys/brds/about/faq.html.
Electronic materials
Electronic versions of the questionnaire and related information are available at
https://www.census.gov/programs-surveys/brds/information.html.
Available materials include:
• PDF copy of the questionnaire
• Excel worksheets for each section that can be completed and uploaded
• Question-by-question instructions, definitions, and examples that provide clarification
• Answers to frequently asked questions, including how the data will be used
Filing electronically
You may submit your survey online via a secure website. Online submission allows you to save the data
as you go, so you can exit and resume later where you left off. It also allows you to save an electronic
copy of your completed survey. To submit online, follow the instructions at
https://www.census.gov/programs-surveys/brds/information.html.
Form BRD-1
2
§,"g<¤
11017035
What is Research and Development (R&D)?
Research and development (R&D) comprise creative and systematic work undertaken in order to increase
the stock of knowledge and to devise new applications of available knowledge. This includes: a) activities
aimed at acquiring new knowledge or understanding without specific immediate commercial applications
or uses (basic research); b) activities aimed at solving a specific problem or meeting a specific commercial
objective (applied research); and c) systematic work, drawing on research and practical experience and
resulting in additional knowledge, which is directed to producing new products or processes or to
improving existing products or processes (development). R&D includes both direct costs such as salaries
of researchers as well as administrative and overhead costs clearly associated with the company’s R&D.
The term R&D does NOT include expenditures for:
• Costs for routine product testing, quality control, and technical services unless they are an integral
part of an R&D project
• Market research
• Efficiency surveys or management studies
• Literary, artistic, or historical projects, such as films, music, or books and other publications
• Prospecting or exploration for natural resources
Does R&D include development of software and Internet applications?
Research and development activity in software and Internet applications refers only to activities with
an element of uncertainty and that are intended to close knowledge gaps and meet scientific and
technological needs. Report in this survey all software R&D as defined here regardless of the eventual
user (internal or external).
R&D activity in software INCLUDES:
• Software development or improvement activities that expand scientific or technological knowledge
• Construction of new theories and algorithms in the field of computer science
R&D activity in software EXCLUDES:
• Software development that does not depend on a scientific or technological advance, such as
• supporting or adapting existing systems
• adding functionality to existing application programs, and
• routine debugging of existing systems and software
• Creation of new software based on known methods and applications
• Conversion or translation of existing software and software languages
• Adaptation of a product to a specific client, unless knowledge that significantly improved the base
program was added in that process
Reporting unit
The reporting unit is your company, including all subsidiaries and divisions regardless of location.
Include only subsidiary companies where there is more than 50 percent ownership. If you are owned
by a foreign parent, the reporting unit for the survey is your U.S.-located company, including all your
majority-owned subsidiaries and divisions regardless of location. For reporting purposes, your foreign
parent and any foreign affiliates your company does not own should be treated the same as any
business partner, customer, or supplier you do not own.
Reporting period
Report data for the calendar year 2017, if possible, or for your company’s fiscal year ending between
April 2017 and March 2018.
Estimates are acceptable
Please report all items to the best of your ability.
To speak with a survey specialist, call 1-800-772-7851.
Survey specialists are available Monday through Friday, from 8:00 a.m. to 5:00 p.m. Eastern time, to help
with any questions you may have.
Form BRD-1
3
§,"gD¤
SECTION 1
11017043
SECTION 1
Company Information
1-1
Has your company ceased operations?
Yes ➔ Please provide the following information:
(MM)
(DD)
(YYYY)
Date your company ceased operations
REPORTING INSTRUCTIONS:
If your company ceased operations between April 1, 2017 and December 31, 2017, report only
for the period January 1, 2017 to the date your company ceased operations. If your company
ceased operations before April 1, 2017, complete Question 1-6 and return this form to the
Census Bureau - you are not required to complete the rest of this survey.
No
1-2
Was your company a majority-owned subsidiary of a foreign company in 2017?
Yes ➔ Please provide the following information and then skip to Question 1-4:
Name of parent company
REPORTING INSTRUCTIONS FOR FOREIGN-OWNED COMPANIES:
If you are owned by a foreign parent, the reporting unit for the survey is your U.S.-located
company, including all your majority-owned subsidiaries and divisions regardless of location. For
reporting purposes, your foreign parent and any foreign affiliates your company does not own
should be treated the same as any business partner, customer, or supplier you do not own.
If you pay your foreign parent for R&D services, those costs should be included in your responses
in Section 2 as "costs for purchased R&D services."
If your foreign parent pays or reimburses your company for R&D services, the costs for this R&D
should be included in your responses in Section 3 as "costs funded, paid for, or reimbursed by
others."
Report your survey data using U.S. Generally Accepted Accounting Principles (U.S. GAAP) as
1-5
recognized
by the
Financial
Accounting operations
Standard Board
Did your
company
have
discontinued
in (FASB).
2017? If your company follows
International Financial Reporting Standards (IFRS), we request that you estimate any adjustments
that➔would
be required
to conform
to U.S. GAAP.
Yes
Include
data for
these operations
in your survey responses
No
No
Form BRD-1
4
§,"gL¤
1-3
Did another U.S. company other than a holding company own more than 50 percent
of the voting interest in your company during 2017?
Yes ➔ Please provide the following information:
Name of parent company
EIN of owner (9 digits)
Date parent
company purchased
your company
(MM)
(DD)
(YYYY)
REPORTING INSTRUCTIONS FOR U.S.-OWNED COMPANIES:
If your company was purchased between April 1, 2017 and December 31, 2017, report only for
the period January 1, 2017 to the date of purchase. If your company was purchased before
April 1, 2017, complete Question 1-6 and return this form to the Census Bureau – you are not
required to complete the rest of this survey unless your owner instructs you to complete this
survey.
No
1-4
Did your company own more than 50 percent of any company operations or
subsidiaries outside the 50 United States and D.C. during 2017?
Yes ➔ Include data for these operations/subsidiaries in your survey responses
11017050
No
1-5
Did your company have discontinued operations in 2017?
Yes ➔ Include data for these operations in your survey responses
No
1-6
Who is the survey coordinator?
The survey coordinator is the person at your company responsible for gathering all requested
information, ensuring instructions are followed, and submitting the completed survey. The
survey coordinator may not be able to personally complete the entire survey and may need
to request information from other knowledgeable resources concerning your company’s R&D,
accounting, human resources, and legal matters.
Name
Title
Telephone
Area code
Number
Extension
E-mail address
Form BRD-1
5
§,"gS¤
SECTION 1
11017050
SECTION 1
11017068
1-7
What was the total number of worldwide employees working at
your company for the pay period that included March 12, 2017?
Include:
• Full- and part-time employees
Number
Exclude:
• Leased or temporary employees and consultants
1-8
How many of the employees reported in Question 1-7 were employees of
your company’s domestic operations and foreign operations?
Domestic operations employees include all employees whose payroll was reported on the
first quarter filing of IRS Form 941, Employer’s Quarterly Tax Return.
(1)
Domestic
operations
(2)
Foreign
operations
(3)
Total
employees
Employees . . . . . . . . . . . .
Total equals Question 1-7
TIP
If the amount reported in Question 1-8, column 1, was less than 10, return this form to the Census
Bureau – you are not required to complete the rest of this survey.
Business Codes
1-9
Do the business code(s) listed below reflect all applicable codes from the list on
pages 46-47 in which your company operated worldwide during 2017?
NOTE: These codes will be used to describe both business activities and R&D activities and
may differ from industry codes used by other government surveys and reports.
If no business codes are printed below, please write in the codes from pages 46-47
that apply to your company.
Yes
No ➔ Draw a line through codes that are incorrect. As needed, enter additional
codes and descriptions from pages 46-47 in the spaces provided.
Business code
(see pages 46-47)
1-10
Description
Please describe your company’s primary business activity during 2017.
Form BRD-1
6
§,"ge¤
1-11
What was the amount of your company’s worldwide sales and revenues
during 2017?
$Bil.
Mil.
SECTION 1
11017076
Thou.
Include:
• Sales and operating revenues from discontinued operations
1-12
How much of the amount reported in Question 1-11 was attributable to or originated
from domestic operations?
Include:
• Sales and operating revenues to foreign customers,
including foreign subsidiaries
Example: U.S. Manufacturing Corporation sells parts to
customers around the world. However, because all its
operations are located inside the United States it reports 100%
of its sales in this question.
$Bil.
Mil.
Thou.
1-13 How much of the 2017 sales and operating revenue amounts was for each business
code listed or amended in Question 1-9:
(1) Worldwide sales and operating revenues reported in Question 1-11
(2) Sales and operating revenues from domestic operations reported in Question 1-12
Business code
(1)
Worldwide sales and
operating revenues
$Bil.
Mil.
Thou.
(2)
Sales and operating revenues
from domestic operations
$Bil.
Mil.
Thou.
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
Less eliminations –
the sales and
revenues that are
eliminated in order
to consolidate the (
business codes. . . .
)(
)
Total . . . . . . . . . .
Total equals Question 1-11
Form BRD-1
7
Total equals Question 1-12
§,"gm¤
11017084
SECTION 2
R&D Paid For by Your Company
SECTION 2
Who should answer this section?
Persons familiar with accounting concepts and with access to financial records related to your company’s
R&D activities should complete this section.
What does this section cover?
This section requests information about your company’s R&D at multiple levels of detail: for your
worldwide consolidated enterprise, for units or parts of your company defined by geography (countries,
states, specific location), and for parts of your company defined by business code.
2-1
What was the worldwide R&D expense (both direct and indirect) for your company
in 2017?
If your company is publicly traded, this amount is equivalent
to that disclosed on SEC Form 10-K as defined in FASB ASC Topic
730, Research and Development.
$Bil.
Mil.
Thou.
If your company is foreign-owned, refer to the instructions on
page 4. Additional guidance, such as for privately owned
companies, is available online at https://www.census.gov/
programs-surveys/brds/information/BRDShelp.html#Q2-1
NOTE: Report your company’s R&D expense even if the amount is
not considered material for your company’s financial statements.
2-2
Does the amount reported in Question 2-1 include any of the following costs?
a. Collaborative R&D that was reimbursed by business partners,
such as through cost-sharing agreements . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
b. R&D paid for by grants (government or private foundations) . . . . . . . . .
Yes
No
c. R&D paid for by customers (customer-sponsored R&D) . . . . . . . . . . . . .
Yes
No
d. Technical services not an integral part of an R&D project (such as
product support provided by R&D employees) . . . . . . . . . . . . . . . . . . . .
Yes
No
e. Bid and proposal costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
f. Expense your company claimed resulting from the acquisition of
another company with unfinished R&D projects (in-process R&D) . . . . .
Yes
No
Yes
No
g. Phase IV clinical trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
2-3
If you answered "Yes" to any of the costs in Question
2-2, what was the amount of these costs that was
included in your response to Question 2-1?
2-4
Subtract Question 2-3 from Question 2-1 and enter the
result here. This is the total R&D paid for by your
company in 2017.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
Is the amount entered in Question 2-4:
$0 ➔
STOP
Skip to Section 3 on page 19.
Less than $1 Million ➔
Skip to Section 2 Worksheet on page 18 and then
continue with Section 3 on page 19.
STOP
$1 Million or greater ➔ Continue with Question 2-5.
Form BRD-1
8
§,"gu¤
11017092
Indirect R&D charges
How much of the amount reported in Question 2-4
was for R&D costs your company plans to recoup
through indirect charges on U.S. federal government
contracts (IR&D or independent R&D)?
$Bil.
Mil.
Thou.
R&D paid for by your company
2-6
Of the amount reported in Question 2-4, what were the costs for each business
code listed or amended in Question 1-9?
Allocate R&D costs that are applicable to more than one business code on a reasonable
basis. Allocation in proportion to operating revenues is acceptable unless some alternative
allocation basis is more appropriate.
$Bil.
Business code
a.
................................
b.
................................
c.
................................
d.
................................
e.
................................
f.
................................
g.
................................
h.
................................
Mil.
Thou.
i. Total (equals Question 2-4) . . . . . . . . . . . . . . . . . . . . . . . . .
2-7
Of the amount reported in Question 2-4, what costs were incurred by your
company in the following locations?
a. Domestic United States (50 states and D.C.) [Include
R&D performed by domestic operations that is paid
for by foreign subsidiaries] . . . . . . . . . . . . . . . . . . . . . . . . . .
$Bil.
Mil.
Thou.
b. All other countries (also, Puerto Rico) [Include R&D
performed by foreign subsidiaries that is paid for
by domestic operations] . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 2-4). . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
9
§,"g}¤
SECTION 2
2-5
11017100
2-8
How much of the (1) domestic, (2) foreign, and (3) worldwide R&D paid for by
your company in 2017 was for each of the following types of costs?
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
SECTION 2
a. Salaries, wages, and fringe benefits
b. Stock-based compensation
c. Leased employees or temporary staffing, including on-site consultants, working on R&D
d. Expensed equipment (not capitalized)
e. Materials and supplies
f. Leased facilities and equipment
g. Depreciation and amortization on R&D property, plant, and equipment
h. Royalties and licensing fees (including payments made to others for the use of patents and other forms of intellectual
property used in your company’s R&D)
i. Payments to business partners for collaborative R&D (exclude
royalties and licensing fees)
j. Purchased R&D services (if your company is foreign-owned, include payments to your foreign parent for R&D)
k. All other purchased services except R&D
l. All other costs (including
administrative and overhead costs clearly associated with your company’s R&D)
Question continues on next page
Form BRD-1
10
§,"h!¤
11017118
2-8
(Continued)
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
Total equals Question 2-7, line a
2-9
Total equals Question 2-7, line b
Total equals Question 2-4
Add 2-8, lines i and j for each column, and enter the result here.
This is R&D performed by others.
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
2-10 Subtract 2-9 from 2-8, line m, for each column and enter the result here.
This is R&D performed by your company.
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
2-11 Of the amount reported in Question 2-10, column 2, how much R&D was performed
in the following locations? For full list of countries in each region see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q2-11.
$Bil.
Mil.
$Bil.
Thou.
Canada . . . . . . .
Germany . . . . . .
Puerto Rico . . . .
Hungary. . . . . . .
Europe
$Bil.
Mil.
Mil.
Thou.
Ireland . . . . . . . .
Thou.
Austria. . . . . . . .
Italy . . . . . . . . . .
Belgium . . . . . . .
Luxembourg . . .
Czech Rep . . . . .
Netherlands . . . .
Denmark . . . . . .
Norway . . . . . . .
Finland . . . . . . .
Poland . . . . . . . .
France . . . . . . . .
Russia . . . . . . . .
Question continues on next page
Form BRD-1
11
§,"h3¤
SECTION 2
m. Total
11017126
2-15
2-11 (Continued)
SECTION 2
$Bil.
Mil.
Thou.
Spain . . . . . . . . .
New Zealand . . .
Sweden . . . . . . .
Singapore . . . . .
Switzerland . . . .
South Korea . . .
Turkey . . . . . . . .
Taiwan . . . . . . .
United
Kingdom . . . . . .
Thailand . . . . . .
Other
Europe. . . . . . . .
Other Asia/
Pacific . . . . . . . .
Latin America/
Other Western
Hemisphere
$Bil.
Mil.
Thou.
Middle East
Argentina . . . . . .
Israel . . . . . . . . .
Brazil . . . . . . . . .
Other
Middle East . . . .
Chile . . . . . . . . .
Africa
Mexico. . . . . . . .
South Africa . . .
Other Latin
America/OWH. . .
Other Africa . . . .
Asia and Pacific
$Bil.
Mil.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
Total (equals
Question 2-10,
column 2). . . . . .
Thou.
Australia . . . . . .
China . . . . . . . . .
Hong Kong . . . .
India . . . . . . . . .
Indonesia . . . . .
Japan . . . . . . . .
Malaysia . . . . . .
Form BRD-1
12
§,"h;¤
11017134
2-12 How much of the amount reported in Question 2-10, column 1, was performed in
each state (including D.C.) in 2017?
Mil.
$Bil.
Thou.
Alabama . . . . . . .
Maine . . . . . . . . .
Alaska. . . . . . . . .
Maryland . . . . . .
Arizona . . . . . . . .
Massachusetts . .
Arkansas . . . . . .
Michigan . . . . . .
California . . . . . .
Minnesota . . . . .
Colorado. . . . . . .
Mississippi . . . . .
Connecticut . . . .
Missouri . . . . . . .
Delaware . . . . . .
Montana . . . . . . .
District of
Columbia . . . . . .
Nebraska . . . . . .
Florida . . . . . . . .
Nevada . . . . . . . .
Georgia. . . . . . . .
New Hampshire
Hawaii . . . . . . . .
New Jersey. . . . .
Idaho . . . . . . . . .
New Mexico . . . .
Illinois . . . . . . . . .
New York . . . . . .
Indiana . . . . . . . .
North Carolina . .
Iowa . . . . . . . . . .
North Dakota . . .
Kansas . . . . . . . .
Ohio . . . . . . . . . .
Kentucky. . . . . . .
Oklahoma . . . . . .
Louisiana . . . . . .
Oregon . . . . . . . .
Mil.
Thou.
SECTION 2
$Bil.
Question continues on next page
Form BRD-1
13
§,"hC¤
11017142
2-12 (Continued)
SECTION 2
$Bil.
Mil.
Thou.
$Bil.
Pennsylvania. . . .
Vermont . . . . . . .
Rhode Island. . . .
Virginia . . . . . . . .
South Carolina . .
Washington . . . .
South Dakota . . .
West Virginia . . .
Tennessee . . . . .
Wisconsin . . . . .
Texas . . . . . . . . .
Wyoming . . . . . .
Utah . . . . . . . . . .
Total (equals
Question 2-10,
column 1) . . . . . .
Mil.
Thou.
2-13 At what domestic location did your company perform the largest dollar amount of
R&D in 2017?
Address 1
Address 2
City
State
2-14 How much of the amount reported in Question 2-10,
column 1, was from the location identified in
Question 2-13?
Form BRD-1
14
$Bil.
ZIP
Mil.
Thou.
§,"hK¤
11017159
2-15 At what domestic location did your company perform the second largest dollar
amount of R&D in 2017?
Address 1
City
State
2-16 How much of the amount reported in Question 2-10,
column 1, was from the location identified in
Question 2-15?
$Bil.
SECTION 2
Address 2
ZIP
Mil.
Thou.
2-17 Of the domestic R&D performed by your company reported in Question 2-10,
column 1, how much was for each business code reported in Question 2-6?
(1)
Domestic R&D performed
by your company
Business code
$Bil.
a.
................................
b.
................................
c.
................................
d.
................................
e.
................................
f.
................................
g.
................................
h.
................................
Mil.
Thou.
i. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total equals Question 2-10, column 1
Form BRD-1
15
§,"h\¤
11017167
R&D transactions between legal entities under common ownership
SECTION 2
2-18 How much of the domestic R&D performed by your company reported in Question
2-10, column 1, was paid for by your company’s foreign subsidiaries through
inter-company transactions?
Example: Company Y owns a subsidiary in France. In order to
complete the development of a product in 2017, the French
subsidiary paid for R&D performed at Company Y’s U.S. R&D
center. The cost of the U.S. R&D that was paid for by the French
subsidiary would be included in this item.
$Bil.
Mil.
Thou.
2-19 How much of the foreign R&D performed by your company reported in Question
2-10, column 2, was paid for by your company’s domestic subsidiaries through
inter-company transactions?
Example: Company Z owns a subsidiary in France. In order to
complete the development of a product in 2017, the domestic
operations paid for R&D performed at its subsidiary’s R&D center
in France. The cost of the French subsidiary’s R&D that was paid
for by the domestic operations would be included in this item.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
R&D performed by others
2-20 How much of the domestic R&D performed by others
reported in Question 2-9, column 1, was performed by
the following types of organizations?
a. Companies located inside the United States . . . . . . . . . . . . .
b. Your company’s foreign parent (if you are owned by a
foreign parent). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Other companies located outside the United States . . . . . . .
d. U.S. federal government agencies or laboratories . . . . . . . . .
e. U.S. state and local government agencies or laboratories . . .
f. Universities, colleges, and academic researchers (including
principal investigators) located inside the United States . . . .
g. All other organizations inside the United States . . . . . . . . . .
h. All other organizations outside the United States . . . . . . . . .
i. Total domestic R&D paid for by your company that
was performed by others (equals Question 2-9,
column 1). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
16
§,"hd¤
11017175
Activities with academia
2-21 In addition to the amount reported in Question 2-20, line f, did your company make
monetary gifts to U.S. universities or colleges in 2017 that included support for R&D?
Yes ➔ Continue with Question 2-22
2-22 What was the amount of monetary gifts made by
your company to U.S. universities or colleges in 2017
that was for R&D?
$Bil.
Mil.
Thou.
Projected R&D for 2018
2-23 What are your company’s projected 2018 costs for (1) domestic, (2) foreign, and
(3) worldwide R&D paid for by your company?
NOTE: These amounts are the 2018 projections for the amounts
reported in Question 2-8, line m.
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
2-24 How much of the amount reported in Question 2-23,
column 1, is for projected purchased R&D services
and projected payments to business partners for
collaborative R&D?
Form BRD-1
17
$Bil.
(3)
Worldwide
Mil.
Thou.
Domestic
$Bil.
Mil.
Thou.
§,"hl¤
SECTION 2
No ➔ Skip to Question 2-23
11017183
SECTION 2 WORKSHEET
Complete if amount reported in Question 2-4 is less than $1 Million
1
Of the total R&D paid for by your company reported in Question 2-4, what costs
were incurred in the following locations?
SECTION 2
a. Domestic United States (50 states and D.C.) [Include R&D
performed by domestic operations that is paid for by foreign
subsidiaries] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$Mil.
Thou.
b. All other countries (also, Puerto Rico) [Include R&D performed
by foreign subsidiaries that is paid for by domestic operations] . . . . .
c. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2
How much of the amount reported in Question 1, line a was for each of the following
types of costs?
$Mil.
Thou.
$Mil.
Thou.
a. Salaries, wages, and fringe benefits. . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Payments to business partners for collaborative R&D . . . . . . . . . . . . .
c. Purchased R&D services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. All other costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
e. Total (equals Question 1, line a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3
Add Question 2, lines a and d, and enter the result here.
This is the domestic R&D paid for and performed by
your company in 2017.
4
Of the domestic R&D paid for and performed by your company reported in
Question 3, how much was for the following categories?
a. Basic research–activities aimed at acquiring new knowledge
or understanding without specific immediate commercial
applications or uses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$Mil.
Thou.
b. Applied research–activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . . . . . . . . .
c. Development–systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . . . . . . . . .
d. Total (equals Question 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
18
§,"ht¤
11017191
SECTION 3
Costs Paid For by Others
Who should answer this section?
Persons familiar with accounting concepts and with access to financial records related to your
company’s activities paid for by others should complete this section.
What does this section cover?
Topics include customer-sponsored work and activities funded through grants, contracts, and/or
reimbursements. Costs for these activities are requested at multiple levels of detail: for your worldwide
consolidated enterprise, for units or parts of your company defined by geography (countries, states),
and for parts of your company defined by business code.
What were your company’s worldwide costs (both direct and indirect) in 2017 for
the following that were funded, paid for, or reimbursed by others not owned by
your company?
Exclude:
• Costs that were paid for by your company, such as those reported in Question 2-4
• Payments in excess of the actual cost of the work performed (such as profit or fees)
$Bil.
Mil.
Thou.
a. R&D reimbursed by your company’s foreign
parent (if you are owned by a foreign parent) . . . . . . . . . . . .
b. Collaborative R&D reimbursed by business partners,
such as through cost-sharing agreements . . . . . . . . . . . . . . .
c. R&D paid for by grants (government or private
foundations). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. Defense R&D goods or services provided as a prime
or as a sub, to the government and/or government
contractors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exclude:
• Costs for projects that have achieved technical feasibility, such as
low-rate initial production. Additional guidance is available online
at https://www.census.gov/programssurveys/brds/information.html
e. Medical clinical trial Phase I-III services provided to others
not owned by your company (include pass-through costs) . .
f. Medical R&D services, other than clinical trials, provided
to others not owned by your company . . . . . . . . . . . . . . . . .
g. Nondefense custom software development and/or
computer systems designed for others not owned by
your company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exclude:
• Software development that does not depend on a scientific or
technological advance, such as adding functionality to existing
application programs, debugging systems, and adapting
existing software
h. Prototype development, production, and testing for
customer’s products prior to their introduction to the
market (excluding defense-related prototyping reported
in line d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
i. All other R&D services provided to the Federal Government
or to others not owned by your company . . . . . . . . . . . . . . .
j. Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
19
§,"h|¤
SECTION 3
3-1
11017209
3-1
(Continued)
The amount entered in Question 3-1, line j is the total R&D paid for by others in 2017.
Is this amount:
$0 ➔
If Question 2-4 was also $0, then you have completed this survey,
otherwise skip to Section 4 on page 34.
STOP
Less than $1 Million ➔
Skip to Section 3 Worksheet on page 33 and then
continue with Section 4 on page 34.
STOP
$1 Million or greater ➔ Continue with Question 3-2.
R&D paid for by others
SECTION 3
3-2
Of the amount reported in Question 3-1, line j, what costs were incurred
by your company in the following locations?
$Bil.
Mil.
Thou.
a. Domestic United States (50 states and D.C.) . . . . . . . . . . . . .
b. All other countries (also, Puerto Rico) . . . . . . . . . . . . . . . . . .
c. Total (equals Question 3-1, line j) . . . . . . . . . . . . . . . . . . . . .
3-3
How much of the (1) domestic, (2) foreign, and (3) worldwide R&D paid for by others
in 2017 was for each of the following types of costs?
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
a. Salaries, wages, and fringe benefits
b. Stock-based compensation
c. Leased employees or temporary staffing, including on-site consultants, working on R&D
d. Expensed equipment (not capitalized)
e. Materials and supplies
f. Leased facilities and equipment
Question continues on next page
Form BRD-1
20
§,"i*¤
11017217
3-3
(Continued)
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
g. Depreciation and amortization on R&D property, plant, and equipment
h. Royalties and licensing fees (including payments made to others for the use of patents and other forms of intellectual
property used in your company’s R&D)
royalties and licensing fees)
j. Purchased R&D services (if your company is foreign-owned, include payments to your foreign parent for R&D)
k. All other purchased services except R&D
l. All other costs (including
administrative and overhead costs clearly associated with your company’s R&D)
m. Total
Total equals Question 3-2, line a
3-4
Total equals Question 3-1, line j
Add 3-3, lines i and j for each column, and enter the result here.
This is R&D performed by others (e.g., subcontracted/passed-through R&D costs).
$Bil.
3-5
Total equals Question 3-2, line b
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
Subtract 3-4 from 3-3, line m, for each column and enter the result here.
This is R&D performed by your company that was paid for by others.
$Bil.
(1)
Domestic
Mil.
Thou.
$Bil.
(2)
Foreign
Mil.
Form BRD-1
21
Thou.
$Bil.
(3)
Worldwide
Mil.
Thou.
§,"i2¤
SECTION 3
i. Payments to business partners for collaborative R&D (exclude
11017225
3-6
Of the amount reported in Question 3-5, column 2, how much R&D was performed
in the following locations? For full list of countries in each region see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q3-6.
$Bil.
Mil.
Thou.
Canada . . . . . . .
Switzerland . . . .
Puerto Rico . . . .
Turkey . . . . . . . .
Europe
$Bil.
Mil.
Thou.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
United
Kingdom . . . . . .
Austria . . . . . . .
Other
Europe. . . . . . . .
Belgium . . . . . . .
SECTION 3
$Bil.
Latin America/
Other Western
Hemisphere
Czech Rep . . . . .
Argentina. . . . . .
Denmark . . . . . .
Brazil . . . . . . . . .
Finland . . . . . . .
Chile . . . . . . . . .
France . . . . . . . .
Mexico. . . . . . . .
Germany . . . . . .
Other Latin
America/OWH . .
Hungary . . . . . . .
Asia and Pacific
Ireland . . . . . . . .
Australia . . . . . .
Italy . . . . . . . . . .
China. . . . . . . . .
Luxembourg . . .
Hong Kong . . . .
Netherlands . . . .
India . . . . . . . . .
Norway . . . . . . .
Indonesia . . . . .
Poland . . . . . . . .
Japan . . . . . . . .
Russia . . . . . . . .
Malaysia . . . . . .
Spain . . . . . . . . .
New Zealand . . .
Sweden . . . . . . .
Singapore . . . . .
Question continues on next page
Form BRD-1
22
§,"i:¤
11017233
3-6
(Continued)
$Bil.
Mil.
Thou.
Africa
South Korea . . .
South Africa. . . .
Taiwan . . . . . . .
Other Africa . . . .
Thailand . . . . . .
Total (equals
Question 3-5,
column 2). . . . . .
$Bil.
Mil.
Thou.
Other Asia/
Pacific . . . . . . . .
$Bil.
Mil.
Thou.
Israel . . . . . . . . .
Other
Middle East . . . .
3-7
How much of the domestic R&D performed by your company that was paid for by
others reported in Question 3-5, column 1, was for each business code listed or
amended in Question 1-9?
Allocate R&D that is applicable to more than one business code on a reasonable basis.
Allocation in proportion to operating revenues is acceptable unless some alternative allocation
basis is more appropriate.
Business code
$Bil.
a.
................................
b.
................................
c.
................................
d.
................................
e.
................................
f.
................................
g.
................................
h.
................................
Mil.
Thou.
i. Total (equals Question 3-5, column 1) . . . . . . . . . . . . . . . . .
Form BRD-1
23
§,"iB¤
SECTION 3
Middle East
11017241
3-8
How much of the amount reported in Question 3-5, column 1, was paid for by each
of the following?
If your company is a subcontractor or subgrantee, report the original source of funds.
Example: Company Sub Inc. performs custom software development for a large defense company as
a subcontractor on a contract with the U.S. Dept. of Defense. Even though Sub Inc. is working directly
for the defense company, it reports the cost of this development in line d because the Dept. of Defense
was the original source of funds.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Other companies located inside the United States. . . . . . . . .
b. Your company’s foreign parent (if you are owned by a
foreign parent). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SECTION 3
c. Other companies located outside the United States . . . . . . .
d. U.S. federal government agencies or laboratories . . . . . . . . .
e. U.S. state government agencies or laboratories . . . . . . . . . .
f. Foreign government agencies or laboratories . . . . . . . . . . . .
g. Universities, colleges, and academic researchers (including
principal investigators) located inside the United States . . . .
h. Universities and colleges located outside the United States . .
i. All other organizations inside the United States . . . . . . . . . .
j. All other organizations outside the United States . . . . . . . . .
k. Total (equals Question 3-5, column 1). . . . . . . . . . . . . . . . . .
3-9
Add Question 3-8, lines a, b, and c, and enter the
result here. This is the domestic R&D performed by
your company that was paid for by other companies.
Form BRD-1
24
§,"iJ¤
11017258
3-10 Using the list of business codes printed below, allocate the amount reported in
Question 3-9 based on the industries of the companies that paid for the R&D.
As needed, enter additional codes from pages 46-47 in the spaces provided.
Business code
Description
a.
3 2 5 4 3
Biotechnology-based pharmaceutical
and biological products (except
diagnostics) . . . . . . . . . . . . . . . . . . . . . .
b.
3 2 5 4
1
Pharmaceutical, medicinal, and
botanical products manufacturing . . . . .
c.
3 3 5 0 0
Electrical equipment, appliances, and
components manufacturing . . . . . . . . . .
d.
3 3 4 4 0
Semiconductor and other electronic
components manufacturing . . . . . . . . . .
e.
3 3 9
1
0
Medical equipment and supplies
manufacturing . . . . . . . . . . . . . . . . . . . .
f.
3 3 6
1
0
Motor vehicles manufacturing . . . . . . . .
g.
..
h.
..
i.
..
j.
Total (equals Question 3-9) . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
25
Mil.
Thou.
SECTION 3
$Bil.
§,"i[¤
11017266
3-11 How much of the amount reported in Question 3-8, line d,
was paid for by the following agencies?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Department of Defense . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Department of Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. National Aeronautics and Space Administration . . . . . . . . . .
d. National Institutes of Health . . . . . . . . . . . . . . . . . . . . . . . . . .
SECTION 3
e. Department of Homeland Security . . . . . . . . . . . . . . . . . . . . .
f. Department of Transportation . . . . . . . . . . . . . . . . . . . . . . . .
g. Environmental Protection Agency. . . . . . . . . . . . . . . . . . . . . .
h. National Science Foundation . . . . . . . . . . . . . . . . . . . . . . . . .
i. All other, please specify:
....
j. Total (equals Question 3-8, line d) . . . . . . . . . . . . . . . . . . . .
3-12 How much of the amount reported in Question 3-8, line d,
was performed under the following types of agreements?
a. Contracts (include direct or prime contracts and
subcontracts). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Grants, reimbursements, and all other agreements . . . . . . . .
c. Total (equals Question 3-8, line d) . . . . . . . . . . . . . . . . . . . . .
3-13 Subtract Question 3-8, line d, from Question 3-8, line k,
and enter the result here. This is the domestic R&D
performed by your company that was paid for by
nonfederal sources.
Form BRD-1
26
§,"ic¤
11017274
3-14 How much of the following three amounts was performed in each state
(including D.C.):
(1) Domestic R&D paid for by the U.S. federal government reported in Question 3-8,
line d
(2) Domestic R&D paid for by nonfederal sources reported in Question 3-13
(3) Total domestic R&D performed by your company that was paid for by others
reported in Question 3-5, column 1
$Bil.
(1)
Federal
Mil.
Thou.
$Bil.
(2)
Nonfederal
Mil.
Thou.
$Bil.
(3)
Total
Mil.
Thou.
Alabama
SECTION 3
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Question continues on next page
Form BRD-1
27
§,"ik¤
11017282
3-14 (Continued)
$Bil.
(1)
Federal
Mil.
Thou.
$Bil.
(2)
Nonfederal
Mil.
Thou.
$Bil.
(3)
Total
Mil.
Thou.
Idaho
Illinois
Indiana
SECTION 3
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Question continues on next page
Form BRD-1
28
§,"is¤
11017290
3-14 (Continued)
$Bil.
(1)
Federal
Mil.
Thou.
$Bil.
(2)
Nonfederal
Mil.
Thou.
$Bil.
(3)
Total
Mil.
Thou.
Missouri
Montana
Nebraska
SECTION 3
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Question continues on next page
Form BRD-1
29
§,"i{¤
11017308
3-14 (Continued)
$Bil.
(1)
Federal
Mil.
Thou.
$Bil.
(2)
Nonfederal
Mil.
Thou.
$Bil.
(3)
Total
Mil.
Thou.
Pennsylvania
Rhode Island
South Carolina
SECTION 3
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Question continues on next page
Form BRD-1
30
§,"j)¤
11017316
3-14 (Continued)
$Bil.
(1)
Federal
Mil.
Thou.
$Bil.
(2)
Nonfederal
Mil.
Thou.
$Bil.
(3)
Total
Mil.
Thou.
Total
Total equals Question 3-8, line d
Total equals Question 3-13
Total equals Question 3-5, column 1
3-15 At what domestic location did your company perform the largest dollar amount of
R&D that was paid for by others in 2017?
Address 1
City
State
3-16 How much of the amount reported in Question 3-5,
column 1, was from the location identified in
Question 3-15?
$Bil.
SECTION 3
Address 2
ZIP
Mil.
Thou.
3-17 At what domestic location did your company perform the second largest dollar
amount of R&D that was paid for by others in 2017?
Address 1
Address 2
City
State
3-18 How much of the amount reported in Question 3-5,
column 1, was from the location identified in
Question 3-17?
Form BRD-1
31
$Bil.
ZIP
Mil.
Thou.
§,"j1¤
11017324
R&D performed by others
3-19 Of the domestic R&D performed by others reported
in Question 3-4, column 1, how much was paid for by
U.S. federal government agencies or laboratories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
Projected R&D paid for by others in 2018
3-20 What are your company’s projected 2018 costs for R&D
that will be paid for by others?
SECTION 3
NOTE: This amount is the 2018 projection for what is
reported in Question 3-1, line j.
3-21 How much of the projected costs in 2018 for R&D that
will be paid for by others reported in Question 3-20 will
be performed by your company in the United States?
NOTE: This amount is the 2018 projection for what is
reported in Question 3-5, column 1.
3-22 How much of the projected costs in 2018 for domestic
R&D performed by your company reported in Question
3-21 will be paid for by the U.S. federal government?
NOTE: This amount is the 2018 projection for what is
reported in Question 3-8, line d.
Form BRD-1
32
§,"j9¤
11017332
SECTION 3 WORKSHEET
Complete if amount reported in Question 3-1, line j is less than $1 Million
1
Of the total R&D paid for by others reported in Question 3-1, line j, what costs
were incurred in the following locations?
$Mil.
Thou.
a. Domestic United States (50 states and D.C.) . . . . . . . . . . . . . . . . . . . .
b. All other countries (also, Puerto Rico) . . . . . . . . . . . . . . . . . . . . . . . . .
2
How much of the amount reported in Question 1, line a, was for each of the
following types of costs?
$Mil.
Thou.
$Mil.
Thou.
a. Salaries, wages, and fringe benefits . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Payments to business partners for collaborative R&D . . . . . . . . . . . . .
c. Purchased R&D services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. All other costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
e. Total (equals Question 1, line a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3
Add Question 2, lines a and d, and enter the result here.
This is the domestic R&D performed by your company
that was paid for by others in 2017.
4
Of the domestic R&D performed by your company that was paid for by others
reported in Question 3, how much was for the following categories?
a. Basic research–activities aimed at acquiring new knowledge
or understanding without specific immediate commercial
applications or uses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$Mil.
Thou.
b. Applied research–activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . . . . . . . . .
c. Development–systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . . . . . . . . .
d. Total (equals Question 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
33
§,"jA¤
SECTION3-EZ
3
WORKSHEET
c. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11017340
SECTION 4
Capital Expenditures
Who should answer this section?
Persons familiar with your company’s accounting for capital expenditures and with access to records
related to those expenditures should complete this section.
What does this section cover?
This section requests financial information about your company’s capital expenditures, specifically those
for R&D operations.
What was the amount of your company’s capital
expenditures in the domestic United States in 2017?
4-2
How much of the amount reported in Question 4-1
was for R&D operations?
4-3
How much of the amount reported in Question 4-2 was
for the following?
SECTION 4
4-1
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Land and structures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. All other capital expenditures for R&D operations . . . . . . . . .
e. Total domestic capital expenditures for R&D
(equals Question 4-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4-4
Was any of the amount reported in Question 4-2 funded,
paid for, or reimbursed by others not owned by your
company (including your foreign parent)? . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
34
Yes
§,"jI¤
No
11017357
SECTION 5
Management and Strategy of R&D
Who should answer this section?
Persons familiar with the technical, managerial, and strategic aspects of your company’s R&D should
complete this section.
What does this section cover?
This section requests information about the characteristics of the R&D reported in Sections 2 and 3.
This section requests information about your company’s worldwide consolidated R&D and the R&D
your company performs in the domestic United States.
TIP
If the amount reported in Question 2-4 was less than $1 Million, skip to Question 5-15 on page 37.
5-1
What percentage of the total R&D paid for by your company reported in Question 2-4
was directed toward business areas or product lines that are new to your company?
Example: Company A manufactures laptop computers. In 2017 Company A’s
management decided to attempt to enter the cellular phone market and used a portion
of the company’s R&D budget to develop cellular phones. Because this was a new line
of business in 2017, Company A reports this R&D in this question.
%
Characteristics of domestic R&D paid for and performed by your company
5-2
Copy the amount from Question 2-10, column 1.
This is the domestic R&D paid for and performed
by your company.
5-3
How much of the amount reported in Question 5-2
was for the following categories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
SECTION 5
a. Research–planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development–systematic work, drawing on research
and practical experience and resulting in additional
knowledge, which is directed to producing new
products or processes or to improving existing
products or processes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-2) . . . . . . . . . . . . . . . . . . . . . . . . . .
5-4
If you reported any research in Question 5-3, line a, how
much of that research was for the following categories?
a. Applied research–activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .
b. Basic research–activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-3, line a) . . . . . . . . . . . . . . . . . . . .
Form BRD-1
35
§,"jZ¤
11017365
Areas of application for domestic R&D paid for and performed by your
company
NOTE: You may report the same R&D in multiple areas for Questions 5-5 to 5-9.
5-5
What percentage of the amount reported in Question 5-2 had
energy applications, including energy production, distribution,
storage, and efficiency (excluding exploration and prospecting)?
Example: Company B is a semiconductor manufacturer. Its products are not designed
specifically for energy applications. In 2017, 10% of the domestic R&D performed by
the company was focused on improving the energy efficiency of its products. Based on
this, Company B reports "10%" for this question.
%
What percentage of the amount reported in Question 5-2 had
environmental protection applications, including pollution
abatement?
%
What percentage of the amount reported in Question 5-2 had
defense applications, including military applications and
homeland security-related R&D?
%
5-8
What percentage of the amount reported in Question 5-2 had
health or medical applications?
%
5-9
What percentage of the amount reported in Question 5-2 had
agricultural applications?
%
5-6
5-7
SECTION 5
Technology focus of domestic R&D paid for and performed by your company
NOTE: You may report the same R&D in multiple areas for Questions 5-10 to 5-12.
5-10 What percentage of the amount reported in Question 5-2 was for
software products or software embedded in other projects or
products?
%
5-11 What percentage of the amount reported in Question 5-2 was for
biotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q5-11
Biotechnology – The application of science and technology to living organisms,
as well as parts, products and models thereof, to alter living or non-living materials
for the production of knowledge, goods and services.
%
5-12 What percentage of the amount reported in Question 5-2 was for
nanotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q5-12
Nanotechnology – The application of science and technology to organisms,
organic and inorganic materials as well as parts, products, and models thereof,
at the nanometer-scale (but not exclusively below 1000 nanometers).
Form BRD-1
36
%
§,"jb¤
11017373
Characteristics of foreign R&D paid for and performed by your company
5-13 Copy the amount from Question 2-10, column 2.
This is the foreign R&D paid for and performed
by your company.
5-14 How much of the foreign R&D paid for and performed
by your company reported in Question 5-13 was for
the following categories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Research–planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development–systematic work, drawing on research
and practical experience and resulting in additional
knowledge, which is directed to producing new
products or processes or to improving existing
products or processes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-13) . . . . . . . . . . . . . . . . . . . . . . . . .
Domestic R&D performed by your company that was paid for by others
If the amount reported in Question 3-1, line j was less than $1 Million, skip to Section 6 on page 40.
5-15 Copy the amount from Question 3-5, column 1. This
is the domestic R&D performed by your company that
was paid for by others.
5-16 How much of the amount reported in Question 5-15
was for the following categories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Research–planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development–systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-15) . . . . . . . . . . . . . . . . . . . . . . . . .
5-17 If you reported any research in Question 5-16, line a, how
much of that research was for the following categories?
a. Applied research–activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .
b. Basic research–activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-16, line a). . . . . . . . . . . . . . . . . . . .
Form BRD-1
37
§,"jj¤
SECTION 5
TIP
11017381
NOTE: You may report the same R&D in multiple areas for Questions 5-18 to 5-22.
5-18 What percentage of the amount reported in Question 5-15 had
energy applications, including energy production, distribution,
storage, and efficiency (excluding exploration and prospecting)?
%
5-19 What percentage of the amount reported in Question 5-15 had
environmental protection applications, including pollution
abatement?
%
5-20
What percentage of the amount reported in Question 5-15 had
defense applications, including military applications and
homeland security-related R&D?
%
5-21
What percentage of the amount reported in Question 5-15 had
health or medical applications?
%
5-22
What percentage of the amount reported in Question 5-15 had
agricultural applications?
%
Technology focus of domestic R&D performed by your company that was
paid for by others
NOTE: You may report the same R&D in multiple areas for Questions 5-23 to 5-25.
SECTION 5
5-23 What percentage of the amount reported in Question 5-15 was for
software products or software embedded in other projects or
products?
%
5-24 What percentage of the amount reported in Question 5-15 was for
biotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q5-24
Biotechnology – The application of science and technology to living organisms,
as well as parts, products and models thereof, to alter living or non-living materials
for the production of knowledge, goods and services.
%
5-25 What percentage of the amount reported in Question 5-15 was for
nanotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/BRDShelp.html#Q5-25
Nanotechnology – The application of science and technology to organisms,
organic and inorganic materials as well as parts, products, and models thereof,
at the nanometer-scale (but not exclusively below 1000 nanometers).
Form BRD-1
38
%
§,"jr¤
11017399
Domestic R&D performed by your company that was paid for by the
U.S. federal government
5-26 Copy the amount from Question 3-8, line d. This is
the domestic R&D performed by your company that
was paid for by the U.S. federal government.
5-27 How much of the amount reported in Question 5-26
was for the following categories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Research–planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development–systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-26) . . . . . . . . . . . . . . . . . . . . . . . . .
5-28 If you reported any research in Question 5-27, line a,
how much was for the following categories?
a. Applied research–activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .
b. Basic research–activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
5-29 What percentage of the amount reported in Question 5-26 was
for software products or software embedded in other projects
or products?
%
Characteristics of foreign R&D performed by your company that was paid
for by others
5-30 Copy the amount from Question 3-5, column 2. This is
the foreign R&D performed by your company and paid
for by others.
5-31 How much of the amount reported in Question 5-30
was for the following categories?
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
a. Research–planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development–systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-30) . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
39
§,"jƒ¤
SECTION 5
c. Total (equals Question 5-27, line a). . . . . . . . . . . . . . . . . . . .
11017407
SECTION 6
Human Resources
Who should answer this section?
Persons familiar with human resources concepts and with access to records related to your company’s
employees should complete this section.
What does this section cover?
This section requests information about your company’s employees, focusing on those who worked on
R&D activities either full-time or part-time. Include employment data for operations or subsidiaries for
which your company owned more than 50 percent.
6-1
How many employees reported in Question 1-8 were R&D employees and how
many were all other employees?
R&D employees include all employees who work on R&D or who provide direct support
to R&D, such as researchers, R&D managers, technicians, clerical staff, and others assigned
to R&D groups. Exclude employees who provide only indirect support to R&D, such as
corporate personnel, security guards, and cafeteria workers.
(1)
Domestic
operations
(2)
Foreign
operations
(3)
Total
employees
a. R&D employees . . . . . .
b. All other employees . . .
c. Total employees . . . . .
Total line equals Question 1-8
R&D employees
6-2
How many of the R&D employees reported in Question 6-1, line a, were female
employees and male employees?
(1)
Domestic
operations
(2)
Foreign
operations
(3)
Total R&D
employees
SECTION 6
a. Female R&D employees
b. Male R&D employees . .
c. Total R&D employees
Total line equals Question 6-1, line a
Form BRD-1
40
§,"k(¤
11017415
6-3
How many of the R&D employees reported in Question 6-1, line a, worked in the
occupations listed below?
a. Researchers (including
R&D scientists,
engineers, and their
managers) . . . . . . . . . . .
(1)
Domestic
operations
(2)
Foreign
operations
(3)
Total R&D
employees
b. R&D technicians and
equivalent staff . . . . . . .
c. R&D support staff
(clerical and other) . . . .
d. Total R&D employees
Total line equals Question 6-1, line a
6-4
How many of the researchers reported in Question 6-3, line a, had the following
level of education?
(1)
(2)
(3)
Domestic
Operations
Foreign
Operations
Total
PhD (excluding MD,
JD, and EdD) . . . . . . . . . . .
Domestic full-time equivalents (FTEs)
6-5
Of the domestic R&D employees reported in Question 6-1, line a, column 1, what
was the number of full-time equivalents (FTEs) for R&D activity for full-time R&D
employees, other full-time employees not working solely on R&D, and part-time
employees?
Number
a. FTEs for full-time R&D employees
Count the number of full-time employees who work only on R&D. . . . .
Example:
50 full-time R&D employees worked only on R&D = 50 FTEs
b. FTEs for other full-time employees not working solely on R&D
........
Example:
60 full-time employees averaged one-fourth of their time on R&D = 15 FTEs
c. FTEs for part-time employees working on R&D
Use the share of a full-time week (such as 40 hours) that they work
on R&D to calculate the FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
20 part-time employees averaged 20 hours a week on R&D activities = 10 FTEs
d. Total FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total FTEs should not exceed Question 6-1, line a, column 1.
Form BRD-1
41
§,"k0¤
SECTION 6
Use the share of the time they work on R&D to calculate the
number of FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11017423
6-6
Of the domestic researchers reported in Question 6-3, line a, column 1, what was
the number of full-time equivalents (FTEs) for R&D activity for full-time R&D
employees, other full-time employees not working solely on R&D, and part-time
employees?
Number
a. FTEs for full-time researchers
Count the number of full-time employees who work only on R&D. . . . .
Example:
50 full-time R&D scientists worked only on R&D = 50 FTEs
b. FTEs for other full-time researchers not working solely on R&D
Use the share of the time they work on R&D to calculate the
number of FTEs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
60 full-time managers averaged one-fourth of their time on R&D = 15 FTEs
c. FTEs for part-time researchers working on R&D
Use the share of a full-time week (such as 40 hours) that they work
on R&D to calculate the FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
20 part-time employees averaged 20 hours a week on R&D activities = 10 FTEs
d. Total FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total FTEs should not exceed Question 6-3, line a, column 1.
6-7
How many of the domestic researchers reported in Question 6-3, line a, column 1,
were non-U.S. citizens employed in the United States under a temporary visa, such
as H-1B or L-1?
(1)
Domestic
Operations
SECTION 6
Researchers employed under a temporary visa . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
42
§,"k8¤
11017431
SECTION 7
Intellectual Property and Technology Transfer
Who should answer this section?
Persons with an understanding of your company’s general business strategy and knowledge of its
patenting, licensing, and other activities related to intellectual property should complete this section.
What does this section cover?
This section requests information about your company’s worldwide intellectual property and technology
transfer activities such as: patents, patent licensing, protection of intellectual property, and transfer of
intellectual property.
Are responses to this survey confidential?
Yes. Your responses are completely confidential under Title 13, United States Code, Section 9, and
can only be used to produce statistics. The Census Bureau is not permitted to publicly release your
responses in a way that could identify your business. The law also provides that copies of reports
retained in your files are immune from legal process. In addition, reported data are exempt from
requests made under the Freedom of Information Act.
Total patents and utility patents
Number
7-1
How many total patents did your company apply for in 2017 from
the U.S. Patent and Trademark Office (USPTO)?
7-2
Of the patent applications reported in Question 7-1, what was the
number of nonprovisional utility patent applications?
7-3
What percentage of the nonprovisional utility patent applications
reported in Question 7-2 has your company applied for or plans to
apply for in foreign jurisdictions?
%
What percentage of the nonprovisional utility patent applications
reported in Question 7-2 was for inventions that originated within
your company’s organized R&D activities?
%
7-5
What percentage of your company’s inventions considered for
patenting in 2017 resulted in nonprovisional utility patent applications?
%
7-6
How many utility patents were issued to your company in 2017 by
the USPTO?
Number
7-4
SECTION 7
Number
Form BRD-1
43
§,"k@¤
11017449
Utility patent sales and licensing to others
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
7-7
How much revenue did your company receive in
2017 from the sale of utility patents?
7-8
How much revenue did your company receive in
2017 from utility patent licensing?
7-9
Was any of the revenue reported in Questions 7-7
or 7-8 received from companies or organizations
located outside the United States? . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No
Yes
Utility patent purchases and licensing from others
$Bil.
Mil.
Thou.
$Bil.
Mil.
Thou.
7-10 How much did your company pay others in 2017
to purchase utility patents?
7-11 How much did your company pay others in 2017
to license utility patents?
Yes
SECTION 7
7-12 Were any of the payments reported in Questions 7-10
or 7-11 made to companies or organizations located
outside the United States? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1
44
§,"kR¤
No
11017456
Intellectual property transfer activities
7-13 Did your company perform the following activities in 2017?
a. Transferred intellectual property (IP) to others not owned by your
company through participation in technical assistance or
"know how" agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
b. Received IP from others not owned by your company through
participation in technical assistance or "know how" agreements . . . . . .
Yes
No
c. Transferred IP to a spin-off or spin-out of your company. . . . . . . . . . . .
Yes
No
d. Received IP from a parent company as part of a spin-off or spin-out. . .
Yes
No
e. Acquired more than 50% ownership in another company for the
primary purpose of acquiring their IP. . . . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
Yes
No
Yes
No
h. Allowed free use of patents or other IP owned by your company
(for example, open source software) . . . . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
i. Made use of open source patents or other freely available IP not
owned by your company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Yes
No
f. Acquired any financial interest in another company in order to
gain access to their IP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
g. Participated in cross-licensing agreements—the agreements in which
two or more parties grant a license to each other for the use of
the subject matter claimed in one or more of the patents owned
by each party. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intellectual property protection
7-14 During 2017, how important to your company were the
following types of intellectual property protection?
Very
important
Somewhat
important
Not
important
a. Utility patents (patents for invention) . . . . . . . . . . . . . . . . . . . .
b. Design patents (patents for appearance) . . . . . . . . . . . . . . . . . .
c. Trademarks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. Copyrights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
e. Trade secrets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
f. Mask works (copyright protection for semiconductor products)
7-15 Did your company file for the tax credit for increasing
research activities (IRS Form 6765) in 2017? . . . . . . . . . . . . . . . . . . . .
Form BRD-1
45
Yes
§,"kY¤
No
SECTION 7
Research and experimentation tax credit
11017464
Business codes
Consumer Goods
33333
Digital cameras manufacturing
33430
Audio and video equipment manufacturing
31210
Beverage manufacturing
33200
Fabricated metal products manufacturing
31100
Food manufacturing
33700
Furniture and related products manufacturing
32300
Printing and related support activities
32591
Soap, cleaning compound, and toilet
preparations manufacturing
31990
Textile, apparel, and leather products
manufacturing
31220
Tobacco manufacturing
33990
Miscellaneous manufacturing not listed
elsewhere (games, office supplies,
slot machines, etc.)
(used in Sections 1, 2, and 3)
Aerospace and Defense
33642
Aircraft engine and engine parts manufacturing
33641
Aircraft manufacturing
33644
Guided missiles, space vehicles, and parts
manufacturing
33692
Military armored vehicle, tank, and tank
components manufacturing
33452
Search, detection, navigation, guidance,
aeronautical, and nautical system and
instruments manufacturing
33660
Ship and boat building
33643
Other aircraft parts and auxiliary equipment
manufacturing
Automobiles, Motorcycles, and Components
33620
Motor vehicle body and trailer manufacturing
33630
Motor vehicle parts manufacturing
33610
Motor vehicles manufacturing
33691
Motorcycle, bicycle, and parts manufacturing
33651
Railroad rolling stock manufacturing
33660
Ship and boat building
33699
All other transportation equipment
manufacturing
Energy and Mining
33360
Engine, turbine, and power transmission
equipment manufacturing
21200
Mining
33319
Mining, oil, and gas field machinery and
equipment manufacturing
21100
Oil and gas extraction
32401
Petroleum refineries
21300
Support activities for mining,
including oil and gas
Capital Equipment
33311
Agricultural machinery and equipment
manufacturing
33332
Commercial, service industry, temperature
control, and airflow control machinery
manufacturing
33312
Construction machinery manufacturing
33500
Electrical equipment, appliances, and
components manufacturing
33360
Engine, turbine, and power transmission
equipment manufacturing
33322
Industrial machinery manufacturing, except
semiconductor machinery
33390
Metalworking and other general purpose
machinery manufacturing
33319
Mining, oil, and gas field machinery and
equipment manufacturing
33331
Photographic and photocopying equipment
manufacturing
Finance, Insurance, and Real Estate
52200
Finance: banking and credit intermediation
52400
Insurance carriers and related activities
53100
Real estate
52310
Securities, commodity contracts, and other
financial investments and related activities
(including funds and trusts)
Healthcare
32543
Biotechnology-based pharmaceutical and
biological products (except diagnostics)
33451
Electromedical, electrotherapeutic, and
irradiation apparatus manufacturing
62200
Hospitals and nursing care facilities
32542
In vitro diagnostic substances manufacturing
62150
Medical and diagnostic laboratories
33910
Medical equipment and supplies manufacturing
62110
Offices of physicians
32541
Pharmaceutical, medicinal, and botanical
products manufacturing
54173
Research and development services
in biotechnology
54174
Research and development services
in physical, engineering, and life sciences
(except biotechnology)
62199
Other ambulatory health care services
(ambulance, dental, home health care)
Chemicals and Materials
32402
Asphalt paving, roofing, and saturated
materials manufacturing
32510
Basic chemicals manufacturing
32790
Cement, concrete, lime, gypsum, and other
nonmetallic mineral product manufacturing
32710
Clay and glass products manufacturing
21200
Mining
32592
Paint, adhesive, and other chemical
manufacturing
32200
Paper manufacturing
32530
Pesticide, fertilizer, and other agricultural
chemical manufacturing
32600
Plastics and rubber products manufacturing
33100
Primary metal manufacturing
32520
Resin, synthetic rubber, and artificial
synthetic fibers and filaments manufacturing
32591
Soap, cleaning compound, and toilet
preparations manufacturing
32100
Wood products manufacturing
32403
Other petroleum and coal products
manufacturing, including motor oil,
hydraulic fluid, and charcoal
Form BRD-1
46
§,"ka¤
11017472
Information Technology - Goods and Services
33333
Digital cameras manufacturing
51801
Cloud computing applications and internet
based software services
54150
Computer systems design and related services
33412
Computers and peripheral equipment
manufacturing, including magnetic and
optical media
51800
Data processing, hosting, and related services
33500
Electrical equipment, appliances, and
components manufacturing
45411
Electronic shopping and electronic auctions
33459
Measuring and control instruments
manufacturing (not listed elsewhere)
33422
Radio, television, and wireless
communication equipment manufacturing
33440
Semiconductor and other electronic
components manufacturing
33321
Semiconductor machinery manufacturing
51120
Software publishers (except Internet)
33421
Telephone apparatus manufacturing
including routers, modems, and gateways
42500
Wholesale electronic markets and
agents and brokers (business to business)
33429
Other communication equipment
manufacturing (except radio, television,
and wireless communication equipment)
51910
Other information services, including
Internet publishing, broadcasting,
and web search portals
Other Services
72000
Accommodation and food services
56100
Administrative and support services
71000
Arts, entertainment, and recreation
23000
Construction
49200
Couriers, messengers, and express delivery
services
53300
Lessors of nonfinancial intangible assets
(including patent licensing)
55100
Management of companies and enterprises
42300
Merchant wholesalers, durable goods
42400
Merchant wholesalers, nondurable goods
51200
Motion picture and sound recording
(except Internet)
51110
Newspaper, periodical, book, and
directory publishers (except Internet)
53200
Rental and leasing services
44000
Retail trade, except electronic shopping
and electronic auctions
62400
Social assistance services
21300
Support activities for mining,
including oil and gas
48000
Transportation
49300
Warehousing and storage
81000
Other services (not listed elsewhere)
Professional, Scientific, and Technical Services
54180
Advertising and related services
54130
Architectural, engineering, and related services
54150
Computer systems design and related services
54111
Legal, accounting, tax preparation,
bookkeeping and payroll services
54160
Management, scientific, and
technical consulting services
54190
Professional, scientific, and technical services
(not listed elsewhere)
54173
Research and development services in
biotechnology
54174
Research and development services in
physical, engineering, and life sciences
(except biotechnology)
54172
Research and development services in
social sciences and humanities
54140
Specialized design services
Telecommunications and Utilities
51500
Broadcasting (except Internet)
51740
Satellite telecommunications
22100
Utilities
56200
Waste management and remediation services
51710
Wired telecommunications carriers
51720
Wireless telecommunications carriers
(except satellite)
51790
Other telecommunications (not listed elsewhere)
Form BRD-1
47
§,"ki¤
11017480
Is the information reported in this survey reported for the 2017 calendar year?
Yes
No ➔ Enter time period covered below:
(MM)
(MM)
(YYYY)
From
(YYYY)
to
Hours
Approximately how long did it take to complete this survey?
Minutes
:
Remarks (Please use this space below for any explanations that may be essential in understanding your
reported data.)
Thank You – Your Response is Important
Accurate and timely statistical information could not be produced without your continued cooperation
and goodwill. Thank you.
We estimate this survey will take an average of 3.3 hours to complete, including the time for reviewing
instructions, searching existing data sources, gathering and maintaining the data needed, and completing
and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to:
ERD Survey Comments 0607-0912
U.S. Census Bureau
4600 Silver Hill Road
Room ERD-6H128
Washington, DC 20233
You may email comments to [email protected]. Be sure to use “ERD Survey Comments 0607-0912”
as the subject.
Form BRD-1
48
§,"kq¤
| File Type | application/pdf |
| File Modified | 2017-11-03 |
| File Created | 2017-10-27 |